[1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182): 66-71.10.1126/science.7545954]Search in Google Scholar
[2. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995; 378(6559): 789-792.10.1038/378789a0]Search in Google Scholar
[3. Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007; 11(2): 103-5.10.1016/j.ccr.2007.01.010]Search in Google Scholar
[4. Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007; 7(12): 937-948.10.1038/nrc2054]Search in Google Scholar
[5. Ferla R, Calo V, Cascio S, et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 2007; 18 (Suppl 6): vi93-98.10.1093/annonc/mdm234]Search in Google Scholar
[6. Balmana J, Diez O, Castiglione M. BRCA in breast cancer: ESMO clinical recommendations. Ann Oncol. 2009; 20(Suppl 4): 19-20.10.1093/annonc/mdp116]Search in Google Scholar
[7. De Greve J, Sermijn E, De Brakeleer S, Ren Z, Teugels E. Hereditary breast cancer: from bench to bedside. Curr Opin Oncol. 2008; 20(6): 605-613.10.1097/CCO.0b013e3283139173]Search in Google Scholar
[8. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010; 10(4): 293-301.10.1038/nrc2812]Search in Google Scholar
[9. Byrski T, Gronwald J, Huzarski T, et al. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol. 2010; 28(3): 375-379.10.1200/JCO.2008.20.7019]Search in Google Scholar
[10. Neuhausen SL. Founder populations and their uses for breast cancer genetics. Breast Cancer Res. 2000; 2(2): 77-81.10.1186/bcr36]Search in Google Scholar
[11. Freedman ML, Penney KL, Stram DO, et al. A haplotype- based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res. 2005; 65(16): 7516-7522.10.1158/0008-5472.CAN-05-0132]Search in Google Scholar
[12. Ewald IP, Ribeiro PL, Palmero EI, Cossio SL, Giugliani R, Ashton-Prolla P. Genomic rearrangements in BRCA1 and BRCA2: A literature review. Genet Mol Biol. 2009; 32(3): 437-446.10.1590/S1415-47572009005000049]Search in Google Scholar
[13. Cox DG, Kraft P, Hankinson SE, Hunter DJ. Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res. 2005; 7(2): R171-R175.10.1186/bcr973]Search in Google Scholar
[14. Qiu LX, Yao L, Xue K, et al. BRCA2 N372H polymorphism and breast cancer susceptibility: a metaanalysis involving 44,903 subjects. Breast Cancer Res Treat. 2010; 123(2): 487-490. 10.1007/s10549-010-0767-5]Search in Google Scholar